Pharmacokinetic and Ulcerogenic Studies of Naproxen Prodrugs Designed for Specific Brain Delivery

被引:16
作者
Sheha, Mahmoud [1 ]
机构
[1] Assiut Univ, Coll Pharm, Med & Pharmaceut Chem Dept, Assiut 71526, Egypt
关键词
Nap prodrug; Pharmacokinetic; Ascorbic acid; Brain delivery; Dihydropyridine-Pyridinium CDS; ALZHEIMERS-DISEASE; DEHYDROASCORBIC ACID; GAMMA-SECRETASE; ASCORBIC-ACID; IN-VITRO; NSAIDS; MECHANISMS; INHIBITOR; DRUGS;
D O I
10.1007/s12272-012-0316-3
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Naproxen (Nap) is an NSAID used as a neuroprotective agent to treat several neurodegenerative diseases. The observed limited brain bioavailability of the drug prompted the design of several chemical delivery systems. We report the synthesis and preliminary in vitro and in vivo investigations of Nap prodrugs with dihydropyridine (I) and ascorbic acid (II) through an ester spacer to target specific brain delivery of Nap. The purpose of this study was to determine the brain bioavailability of Nap after oral administration of the prodrugs in rats. The results showed moderate oral bioavailability of prodrugs (AUC = 53-94 h.mu g/mL) in rats compared with parent Nap (AUC = 155 h.mu g/mL) at equimolar doses. Contrarily, there was a twofold increase in Nap levels in the brain with the prodrugs compared to parent Nap. The enhanced brain bioavailability may be attributed to the specific carrier system in addition to the reduced percentage of plasma protein binding of Nap. Plasma protein binding of the tested prodrugs was investigated in vitro using equilibrium dialysis. The percentage of plasma free fraction of prodrugs (9-15%) was significantly greater than that of Nap (about 5%) when tested at 20 mu M, illustrating more available prodrug to cross the blood brain barrier. A significant decrease in gastric ulcerogenicity of the prodrugs compared with parent Nap was also noted. In conclusion, oral dihydropyridine and ascorbate prodrugs for brain site-specific delivery of Nap may be promising candidates for safe, chronic use of NSAIDs for the treatment of neurodegenerative diseases.
引用
收藏
页码:523 / 530
页数:8
相关论文
共 20 条
[1]   In vitro detection of (S)-naproxen and ibuprofen binding to plaques in the Alzheimer's brain using the positron emission tomography molecular imaging probe 2-(1-{6-[(2[18F]fluoroethyl)(methyl)amino]-2-naphthyl}ethylidene) malononitrile [J].
Agdeppa, ED ;
Kepe, V ;
Petric, A ;
Satyamurthy, N ;
Liu, J ;
Huang, SC ;
Small, GW ;
Cole, GM ;
Barrio, JR .
NEUROSCIENCE, 2003, 117 (03) :723-730
[2]   DELAYED-ONSET OF ALZHEIMERS-DISEASE WITH NONSTEROIDAL ANTIINFLAMMATORY AND HISTAMINE-H2 BLOCKING-DRUGS [J].
BREITNER, JCS ;
WELSH, KA ;
HELMS, MJ ;
GASKELL, PC ;
GAU, BA ;
ROSES, AD ;
PERICAKVANCE, MA ;
SAUNDERS, AM .
NEUROBIOLOGY OF AGING, 1995, 16 (04) :523-530
[3]   NSAID and antioxidant prevention of Alzheimer's disease lessons from in vitro and animal models [J].
Cole, GM ;
Morihara, T ;
Lim, GP ;
Yang, FS ;
Begum, A ;
Frautschy, SA .
PROTECTIVE STRATEGIES FOR NEURODEGENERATIVE DISEASES, 2004, 1035 :68-84
[4]   NSAIDs and enantiomers of flurbiprofen target γ-secretase and lower Aβ42 in vivo [J].
Eriksen, JL ;
Sagi, SA ;
Smith, TE ;
Weggen, S ;
Das, P ;
McLendon, DC ;
Ozols, VV ;
Jessing, KW ;
Zavitz, KH ;
Koo, EH ;
Golde, TE .
JOURNAL OF CLINICAL INVESTIGATION, 2003, 112 (03) :440-449
[5]   Non-steroidal anti-inflammatory drugs (NSAIDs) in Alzheimer's disease: old and new mechanisms of action [J].
Gasparini, L ;
Ongini, E ;
Wenk, G .
JOURNAL OF NEUROCHEMISTRY, 2004, 91 (03) :521-536
[6]  
Gibaldi M., 1982, Multicompartment models, V2nd, P45
[7]   Prodrug Designing of NSAIDs [J].
Halen, Parmeshwari K. ;
Murumkar, Prashant R. ;
Giridhar, Rajani ;
Yadav, Mange Ram .
MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2009, 9 (01) :124-139
[8]   ROLE OF CALCITONIN GENE-RELATED PEPTIDE AND NITRIC-OXIDE IN THE GASTROPROTECTIVE EFFECT OF CAPSAICIN IN THE RAT [J].
LAMBRECHT, N ;
BURCHERT, M ;
RESPONDEK, M ;
MULLER, KM ;
PESKAR, BM .
GASTROENTEROLOGY, 1993, 104 (05) :1371-1380
[9]   Inflammation and Alzheimer's Disease [J].
Lee, Young-Jung ;
Han, Sang Bae ;
Nam, Sang-Yoon ;
Oh, Ki-Wan ;
Hong, Jin Tae .
ARCHIVES OF PHARMACAL RESEARCH, 2010, 33 (10) :1539-1556
[10]  
MOESLINGER T, 1995, CLIN CHEM, V41, P1177